Company Filing History:
Years Active: 2023
Title: Innovations by John P Docherty in Ingestible Event Sensing
Introduction
John P Docherty is an innovative inventor based in New York, NY (US). He has made significant contributions to the field of ingestible event sensing and analysis. His work focuses on developing systems that enhance medication adherence and monitoring through advanced technology.
Latest Patents
John P Docherty holds a patent for "Systems, devices, and methods for ingestible event sensing and analysis." This patent describes a system that includes an ingestible signal generator coupled to a medication. The generator is designed to produce a body-transmissible signal upon ingestion by a user. The system also features a receiver equipped with a sensor that detects the body-transmissible signal. This receiver generates and wirelessly transmits a sensor signal based on the detected signal. Additionally, a user device is included, which has a processor that monitors the sensor for the signal. If the signal is not received within a predetermined time, the processor generates a notification. The processor can also identify trends associated with the sensor signal and the medication, allowing for informed actions based on this data. John P Docherty has 1 patent to his name.
Career Highlights
John P Docherty is currently employed at Otsuka Pharmaceutical Company, Limited. His role involves leveraging his expertise in technology to improve patient outcomes through innovative solutions. His work is pivotal in bridging the gap between medication and technology, ensuring that patients receive timely notifications regarding their medication adherence.
Collaborations
John has collaborated with notable colleagues, including Ainslie Hatch and Ruth Ross. Their combined efforts contribute to the advancement of technology in the pharmaceutical industry.
Conclusion
John P Docherty's contributions to the field of ingestible event sensing represent a significant advancement in medication management. His innovative patent and work at Otsuka Pharmaceutical Company, Limited highlight his commitment to improving patient care through technology.